Paracrine interactions between adipocytes and tumor cells recruit and modify macrophages to the mammary tumor microenvironment: the role of obesity and inflammation in breast adipose tissue

Cancers

Volumn 7, Issue 1, 2015, Pages 143-178

  Santander, Ana M ^a   Lopez Ocejo, Omar ^a   Casas, Olivia ^a   Agostini, Thais ^a   Sanchez, Lidia ^a   Lamas Basulto, Eduardo ^a   Carrio, Roberto ^a   Cleary, Margot P ^b   Gonzalez Perez, Ruben R ^c   Torroella Kouri, Marta ^a,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

Adipocytes; Breast adipose tissue; Breast cancer; Breast tumor cells; Chemotaxis; Diet induced obesity; Inflammation; Macrophages; Obesity; Tumor microenvironment; Tumor progression

Indexed keywords

CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; ERITORAN; FATTY ACID; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INSULIN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 7; LAURIC ACID; LEPTIN; LEPTIN RECEPTOR ANTAGONIST PEPTIDE; LEUKEMIA INHIBITORY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; RECOMBINANT LEPTIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST ADIPOSE TISSUE; BREAST CANCER; BREAST TUMOR; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LIPOLYSIS; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OBESITY; PARACRINE SIGNALING; PHENOTYPE; PROTEIN FUNCTION; SUPERNATANT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

EID: 84922328217     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers7010143     Document Type: Article

References (57)

1. Ogden, C.L.; Carroll, M.D.; Kit, B.K.; Flegal, K.M. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 2012, 82, 1–8.
2. Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N. Engl. J. Med. 2003, 348, 1625–1638.
3. Rose, D.P.; Vona-Davis, L. Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer. Biofactors 2014, 40, 1–12.
4. American Cancer Society. Cancer Facts & Figures 2012; American Cancer Society: Atlanta, GA, USA, 2012.
5. Rose, D.P.; Vona-Davis, L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 2010, 66, 33–38.
6. Suba, Z. Circulatory estrogen level protects against breast cancer in obese women. Recent Pat. Anticancer Drug Discov. 2013, 8, 154–167.
7. Cleary, M.P.; Maihle, N.J. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc. Soc. Exp. Biol. Med. 1997, 216, 28–43.
8. Lumeng, C.N.; Deyoung, S.M.; Bodzin, J.L.; Saltiel, A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56, 16–23.
9. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7, 211–217.
10. Surmi, B.K.; Hasty, A.H. Macrophage infiltration into adipose tissue: Initiation, propagation and remodeling. Future Lipidol. 2008, 3, 545–556.
11. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436–444.
12. Pollard, J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4, 71–78.
13. Qian, B.Z.; Pollard, J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141, 39–51.
14. Pollard, J.W. Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 2008, 84, 623–630.
15. Bingle, L.; Brown, N.J.; Lewis, C.E. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 2002, 196, 254–265.
16. Caso, R.; Silvera, R.; Carrio, R.; Iragavarapu-Charyulu, V.; Gonzalez-Perez, R.R.; Torroella-Kouri, M. Blood monocytes from mammary tumor-bearing mice: Early targets of tumor-induced immune suppression? Int. J. Oncol. 2010, 37, 891–900.
17. Torroella-Kouri, M.; Ma, X.; Perry, G.; Ivanova, M.; Cejas, P.J.; Owen, J.L.; Iragavarapu-Charyulu, V.; Lopez, D.M. Diminished expression of transcription factors nuclear factor kappab and ccaat/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice. Cancer Res. 2005, 65, 10578–10584.
18. Torroella-Kouri, M.; Silvera, R.; Rodriguez, D.; Caso, R.; Shatry, A.; Opiela, S.; Ilkovitch, D.; Schwendener, R.A.; Iragavarapu-Charyulu, V.; Cardentey, Y.; et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither m1 nor m2 and are less differentiated. Cancer Res. 2009, 69, 4800–4809.
19. Torroella-Kouri, M.; Rodriguez, D.; Caso, R. Alterations in macrophages and monocytes from tumor-bearing mice: Evidence of local and systemic immune impairment. Immunol. Res. 2013, 57, 86–98.
20. Rodriguez, D.; Silvera, R.; Carrio, R.; Nadji, M.; Caso, R.; Rodriguez, G.; Iragavarapu-Charyulu, V.; Torroella-Kouri, M. Tumor microenvironment profoundly modifies functional status of macrophages: Peritoneal and tumor-associated macrophages are two very different subpopulations. Cell. Immunol. 2013, 283, 51–60.
21. Fontana, L.; Eagon, J.C.; Trujillo, M.E.; Scherer, P.E.; Klein, S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56, 1010–1013.
22. Subbaramaiah, K.; Howe, L.R.; Bhardwaj, P.; Du, B.; Gravaghi, C.; Yantiss, R.K.; Zhou, X.K.; Blaho, V.A.; Hla, T.; Yang, P.; et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev. Res. 2011, 4, 329–346.
23. Morris, P.G.; Hudis, C.A.; Giri, D.; Morrow, M.; Falcone, D.J.; Zhou, X.K.; Du, B.; Brogi, E.; Crawford, C.B.; Kopelovich, L.; et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev. Res. 2011, 4, 1021–1029.
24. Sugiura, K.; Stock, C.C. Studies in a tumor spectrum. I. Comparison of the action of methylbis (2-chloroethyl)amine and 3-bis(2-chloroethyl)aminomethyl-4-methoxymethyl-5-hydroxy-6-methylpyridine on the growth of a variety of mouse and rat tumors. Cancer 1952, 5, 382–402.
25. Calderon, C.L.; Torroella-Kouri, M.; Dinapoli, M.R.; Lopez, D.M. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine. Int. J. Oncol. 2008, 32, 713–721.
26. Huang, S.; Rutkowsky, J.M.; Snodgrass, R.G.; Ono-Moore, K.D.; Schneider, D.A.; Newman, J.W.; Adams, S.H.; Hwang, D.H. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 2012, 53, 2002–2013.
27. Wong, S.W.; Kwon, M.J.; Choi, A.M.; Kim, H.P.; Nakahira, K.; Hwang, D.H. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284, 27384–27392.
28. Hu, X.; Juneja, S.C.; Maihle, N.J.; Cleary, M.P. Leptin—A growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl. Cancer Inst. 2002, 94, 1704–1711.
29. Rene Gonzalez, R.; Watters, A.; Xu, Y.; Singh, U.P.; Mann, D.R.; Rueda, B.R.; Penichet, M.L. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res. 2009, 11, eR36.
30. Gonzalez, R.R.; Cherfils, S.; Escobar, M.; Yoo, J.H.; Carino, C.; Styer, A.K.; Sullivan, B.T.; Sakamoto, H.; Olawaiye, A.; Serikawa, T.; et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (vegf) and its receptor type two (vegf-r2). J. Biol. Chem. 2006, 281, 26320–26328.
31. Guo, S.; Gonzalez-Perez, R.R. Notch, il-1 and leptin crosstalk outcome (nilco) is critical for leptin-induced proliferation, migration and vegf/vegfr-2 expression in breast cancer. PLOS ONE 2011, 6, e21467.
32. Cleary, M.P.; Grande, J.P.; Maihle, N.J. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 956–962.
33. Dogan, S.; Hu, X.; Zhang, Y.; Maihle, N.J.; Grande, J.P.; Cleary, M.P. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res. 2007, 9, eR91.
34. Lumeng, C.N.; Bodzin, J.L.; Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 2007, 117, 175–184.
35. Cinti, S.; Mitchell, G.; Barbatelli, G.; Murano, I.; Ceresi, E.; Faloia, E.; Wang, S.; Fortier, M.; Greenberg, A.S.; Obin, M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46, 2347–2355.
36. Gilbert, C.A.; Slingerland, J.M. Cytokines, obesity, and cancer: New insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 2013, 64, 45–57.
37. Cleary, M.P.; Juneja, S.C.; Phillips, F.C.; Hu, X.; Grande, J.P.; Maihle, N.J. Leptin receptor-deficient MMTV-TGF-alpha/lepr(db)lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp. Biol. Med. 2004, 229, 182–193.
38. Dirat, B.; Bochet, L.; Dabek, M.; Daviaud, D.; Dauvillier, S.; Majed, B.; Wang, Y.Y.; Meulle, A.; Salles, B.; le Gonidec, S.; et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011, 71, 2455–2465.
39. Ando, S.; Catalano, S. The multifactorial role of leptin in driving the breast cancer microenvironment. Nat. Rev. Endocrinol. 2012, 8, 263–275.
40. Guo, S.; Liu, M.; Gonzalez-Perez, R.R. Role of notch and its oncogenic signaling crosstalk in breast cancer. Biochim. Biophys. Acta 2011, 1815, 197–213.
41. Nicolini, A.; Carpi, A.; Rossi, G. Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006, 17, 325–337.
42. Arendt, L.M.; McCready, J.; Keller, P.J.; Baker, D.D.; Naber, S.P.; Seewaldt, V.; Kuperwasser, C. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res. 2013, 73, 6080–6093.
43. Gruen, M.L.; Hao, M.; Piston, D.W.; Hasty, A.H. Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am. J. Physiol. Cell Physiol. 2007, 293, C1481–1488.
44. Rogers, N.H.; Perfield, J.W., 2nd; Strissel, K.J.; Obin, M.S.; Greenberg, A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150, 2161–2168.
45. Ueno, T.; Toi, M.; Saji, H.; Muta, M.; Bando, H.; Kuroi, K.; Koike, M.; Inadera, H.; Matsushima, K. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 2000, 6, 3282–3289.
46. Fujimoto, H.; Sangai, T.; Ishii, G.; Ikehara, A.; Nagashima, T.; Miyazaki, M.; Ochiai, A. Stromal mcp-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int. J. Cancer 2009, 125, 1276–1284.
47. Matarese, G.; Moschos, S.; Mantzoros, C.S. Leptin in immunology. J. Immunol. 2005, 174, 3137–3142.
48. Lee, F.Y.; Li, Y.; Yang, E.K.; Yang, S.Q.; Lin, H.Z.; Trush, M.A.; Dannenberg, A.J.; Diehl, A.M. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am. J. Physiol. 1999, 276, C386–C394.
49. Hendrayani, S.F.; Al-Khalaf, H.H.; Aboussekhra, A. The cytokine il-6 reactivates breast stromal fibroblasts through transcription factor stat3-dependent up-regulation of the rna-binding protein auf1. J. Biol. Chem. 2014, 289, 30962–30976.
50. Dethlefsen, C.; Hojfeldt, G.; Hojman, P. The role of intratumoral and systemic il-6 in breast cancer. Breast Cancer Res. Treat. 2013, 138, 657–664.
51. Vaughan, T.; Li, L. Molecular mechanism underlying the inflammatory complication of leptin in macrophages. Mol. Immunol. 2010, 47, 2515–2518.
52. Vona-Davis, L.; Rose, D.P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr. Relat. Cancer 2007, 14, 189–206.
53. Ben-Neriah, Y.; Karin, M. Inflammation meets cancer, with NF-kappab as the matchmaker. Nat. Immunol. 2011, 12, 715–723.
54. Battle, M.; Gillespie, C.; Quarshie, A.; Lanier, V.; Harmon, T.; Wilson, K.; Torroella-Kouri, M.; Gonzalez-Perez, R.R. Obesity induced a leptin-notch signaling axis in breast cancer. Int. J. Cancer 2014, 134, 1605–1616.
55. Tartaglia, L.A. The leptin receptor. J. Biol. Chem. 1997, 272, 6093–6096.
56. Gutierrez, D.A.; Hasty, A.H. Haematopoietic leptin receptor deficiency does not affect macrophage accumulation in adipose tissue or systemic insulin sensitivity. J. Endocrinol. 2012, 212, 343–351.
57. Sabatino, R.; Antonelli, A.; Battistelli, S.; Schwendener, R.; Magnani, M.; Rossi, L. Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells. PLOS ONE 2014, 9, e101260.